Citation Impact
Citing Papers
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
2012
The phenomenology and treatment of interferon-induced depression
2004
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
2019
Non-alcoholic fatty liver and the gut microbiota
2016
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
2018
Non-alcoholic fatty liver disease
2017
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells
2003
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
Experimental analysis of critical oxygen delivery
2004
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
2019
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Liver fibrosis
2005 Standout
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
Ultrasound elastography: liver
2015
A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France
2012
NOX in liver fibrosis
2007
Antifibrotic Agents for Liver Disease
2005
Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography—Analysis of a cohort of 1031 subjects
2013
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2019
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
2003
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
2016
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
2018
Hepatocellular carcinoma
2021 Standout
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
2018
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
2015
Intestinal microbiota and nonalcoholic steatohepatitis
2017
Bile acids and nonalcoholic fatty liver disease
2016
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Psoriasis
2021 Standout
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
2007
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Multimorbidity and polypharmacy in diabetic patients with NAFLD
2017
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
2006
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
2003
Portal hypertensive bleeding in cirrhosis
2016 Standout
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Non-alcoholic fatty liver disease
2021 Standout
Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®
2014
Mechanisms of Hepatic Fibrogenesis
2008 Standout
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
2010
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
2007
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
Serum Ferritin Is An Independent Predictor of Histologic Severity and Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2011
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
2017
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis
2018
Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
2014
Noninvasive assessment of liver fibrosis
2010
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
FIB-4
2007 Standout
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
2007
Antifibrotic and Hemodynamic Effects of the Early and Chronic Administration of Octreotide in Two Models of Liver Fibrosis in Rats
1998
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
2017
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
2017
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data
2017
Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation
2004
Non-alcoholic fatty liver disease and the interface between primary and secondary care
2018
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Clinical states of cirrhosis and competing risks
2017
The molecular neurobiology of depression
2008 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2009
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Gut microbiota in human metabolic health and disease
2020 Standout
Noninvasive assessment of fibrosis and steatosis in NASH and ASH
2009
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
2017
Liver Fibrogenesis: A New Role for the Renin–Angiotensin System
2005
Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
2019
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Hepatocellular Carcinoma
2019 Standout
A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα
2010 StandoutNobel
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration
2003
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
2015
The Role of Acoustic Radiation Force Impulse Elastography in the Differentiation of Infectious and Neoplastic Liver Lesions
2015
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
2015
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
2020
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
2015
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
2019
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2016
The innate immune receptor TREM-1 promotes liver injury and fibrosis
2018
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
2019
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions
2015
Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy
2016
Works of Frédéric Oberti being referenced
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:
2005
Vascular involvement of the liver in Turner's syndrome
2004
FibroMeters: a family of blood tests for liver fibrosis
2008
A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis
2017
Factors Limiting Complete Tumor Ablation by Radiofrequency Ablation
2007
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
2016
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension
2002
A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C
2011
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis
1999
Diagnostic et quantification de la fibrose hépatique par IRM de diffusion : résultats préliminaires
2004
Reproducibility of Liver Stiffness Measurement by Ultrasonographic Elastometry
2008
A novel panel of blood markers to assess the degree of liver fibrosis†
2005
The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis
2009
Prevention of portal hypertension by propanolol and spironolactone in rats with bile duct ligation
1997
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis
2010
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
2016
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease
2010
Evolution of Noninvasive Tests of Liver Fibrosis Is Associated With Prognosis in Patients With Chronic Hepatitis C
2014
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
2013
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
2019
Comparison of Eight Diagnostic Algorithms for Liver Fibrosis in Hepatitis C
2011
Determination of reliability criteria for liver stiffness evaluation by transient elastography
2012
Comparison of blood tests for liver fibrosis specific or not to NAFLD
2008
Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?
2017
2017
Predictive factors of response to octreotide for the treatment of portal hypertensive rats
2001
New method of cardiac output measurement using ultrasound velocity dilution in rats
2001
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
2015
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis.
2010
[Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti].
1997
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
2015
Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding
2014
Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?
2015
[Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha].
1998